However, the performance on this test tends to be dichotomous, and there is limited evidence that olfactory function continues to decline as the disease progresses, possibly because olfactory dysfunction appears at very early stages and rapidly approaches a floor effect, leaving little room to capture further decline
Semaglutide patients lose an average of 1517% of body weight, while Tirzepatide patients have seen up to 2225%
Alpha Lipoic Acid & Vitamin E Potent antioxidants that manage oxidative nerve damage
Factoren zoals voeding, beweging en consistent gebruik spelen hierbij een belangrijke rol
Common side effects include gastrointestinal issues, which lead to about 10% of patients discontinuing use, as well as risks like hypotension, pancreatitis, and the progression of diabetic retinopathy
It is important to have a consultation with one of our skilled medical professionals before starting any weight loss program to ensure you are in good health and are a good candidate for these treatments